TD Cowen analyst Yaron Werber downgraded IO Biotech (NASDAQ: IOBT) from Buy to Hold.The analyst comments "We are downgrading to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE